Home
TriStem Corporation
TriStem Technology
publications
human studies
Contact Us
Media
F.A.Q.'s
SiteMap
Links
Requires Java Support - Consult your browser help screen
TriStem Corporation

[ Page 1 | 2 | 3 ]

Management Team

The senior management team of TriStem Group includes:
  • Dr. Ilham Saleh Abuljadayel, Group Chief Scientific Officer
  • Mr. Ghazi Dhoot, Group Chairman, President and Chief Executive Officer.

Dr. Ilham Saleh Abuljadayel
Dr. Ilham Saleh Abuljadayel is the sole inventor of the TriStem Technology. She discovered the process of retrodifferentiation in the early nineties and also developed ways of committing the retrodifferentiated cells into a variety of cells/tissue types, including haematopoietic, neuronal, mesenchymal, cardiomyogenic, endothelial and exocrine cell lineages etc. Based on her research, Dr. Abuljadayel co-founded the TriStem Group.
She received her Bachelor's degree in Cell Biology (1985) and her Ph.D in Immunology (1990) from King's College , University of London. Dr. Abuljadayel has been working as a molecular and cellular biologist since 1982 and has published various articles in peer reviewed journals. During the period 1990 to 1997 Dr Abuljadayel worked as a consultant immunologist at the King Fahd Armed Forces Hospital in Jeddah. Dr. Abuljadayel carried out her research at King's College London, the Royal London Hospital and University of Cambridge.

Mr. Ghazi Dhoot
Mr. Ghazi Jaswinder Dhoot is the co-founder of the TriStem Group. Mr. Dhoot received his Bachelor's degree in Mathematical Physics and Astrophysics (1984) from King's College, University of London. After graduation he worked for over 5 years in Corporate Finance with Manufacturers Hanover, London. He then moved to Saudi Arabia with Saudi American Bank where he remained for five years before joining National Commercial Bank in November 1995 as Head of Mergers and Acquisitions.

[ Page 1 | 2 | 3 ]  [ find out about our management team > ]

2001 © TriStem Corporation   |Disclaimer   info@tristemcorp.com